Zhejiang Shengda Bio-Pharm Co., Ltd.

603079

CNE100002W43

Food Processing

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
11.7 ^CNY	+7.24%		+26.49%	-19.70%

Apr. 19	Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 19	Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Zhejiang Shengda Bio-Pharm Co., Ltd. authorizes a Buyback Plan.

April 27, 2023

The Board of Directors of Zhejiang Shengda Bio-Pharm Co., Ltd. has authorized a buyback plan on April 28, 2023.

Latest news about Zhejiang Shengda Bio-Pharm Co., Ltd.

Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 19	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	Apr. 01	CI
China stocks rise as strength in banks offsets developers' falls	Mar. 29	RE
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	Jan. 02	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	23-10-09	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-25	CI
Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.	23-07-03	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. announces an Equity Buyback for CNY 34 million worth of its shares.	23-05-08	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. authorizes a Buyback Plan.	23-04-27	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-24	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. announced that it expects to receive CNY 500 million in funding	23-03-22	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-26	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-29	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-27	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-27	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-12	CI
Zhejiang Shengda Bio-Pharm Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	20-10-25	CI
Certain A Shares of Zhejiang Shengda Bio-Pharm Co., Ltd. are subject to a Lock-Up Agreement Ending on 23-AUG-2020.	20-08-22	CI

Chart Zhejiang Shengda Bio-Pharm Co., Ltd.

Duration

Period

Chart Zhejiang Shengda Bio-Pharm Co., Ltd.

More charts

ZHEJIANG SHENGDA BIO-PHARM CO., LTD. is a China-based company principally engaged in the research, development, production and sales of vitamins and biological preservatives. Its vitamin products mainly include biotin and folic acid. Its biological preservative products mainly include natamycin and nisin. The Company distributes its products in domestic market and to overseas markets.

Sector

Food Processing

Calendar

2024-05-10 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Special Foods & Wellbeing Products

	1st Jan change	Capi.
ZHEJIANG SHENGDA BIO-PHARM CO., LTD.	-19.70%	255M
ZHEJIANG NHU COMPANY LTD.	+11.32%	7.78B
BELLRING BRANDS, INC.	+1.64%	7.38B
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	+10.50%	6.52B
BYHEALTH CO., LTD	-6.69%	3.67B
THE SIMPLY GOOD FOODS COMPANY	-13.48%	3.44B
XIAMEN KINGDOMWAY GROUP COMPANY	-10.10%	1.17B
SIRIO PHARMA CO., LTD.	+8.34%	934M
HERBALIFE LTD.	-42.79%	879M
USANA HEALTH SCIENCES, INC.	-19.74%	836M